Sun Pharmaceutical Industries Limited proudly announces its inclusion in the prestigious S&P Global Sustainability Yearbook 2024. This recognition highlights Sun Pharma’s dedication to corporate sustainability, aligning with Environmental, Social, and Governance (ESG) principles across its operations.
“Sun Pharma continues to focus on delivering sustainable outcomes for all our stakeholders. Sustainability is an integral part of our way of doing business. We are guided by a clear roadmap around our ESG priorities and the S&P Yearbook inclusion is a testament to our progress on the roadmap,” Dilip Shanghvi, Managing Director of the Company said in a statement.
The S&P Global Corporate Sustainability Assessment (CSA) for 2023 evaluated over 9,400 companies worldwide for The Sustainability Yearbook 2024. Out of these, 739 companies, including Sun Pharma, have been recognized for their commitment to corporate sustainability.
